Back to top anchor

Towards a national, equitable & sustainable clinical trial system in Aotearoa NZ

Year:
2020
Duration:
15 months
Approved budget:
$800,000.25
Researchers:
Professor Frank Bloomfield
,
Professor Lisa Stamp
,
Associate Professor Matire Harwood
,
Associate Dean Collin Tukuitonga
,
Dr Christine Walsh
,
Dr Cameron Lacey
,
Dr Colin McArthur
,
Professor Katrina Sharples
,
Professor Stuart Dalziel
,
Dr Irene Braithwaite
,
Professor Mark Gahegan
,
Dr Deborah Schlichting
,
Professor Dr Nicolette Sheridan
,
Dr Sarah Benge
,
Professor Ngaire Kerse MNZM
,
Professor Christopher Bullen
,
Associate Professor Conroy Wong
,
Professor David Baxter
,
Associate Professor Garry Nixon
,
Mr Charles Stratton
Health issue:
Other (generic health or health services)
Proposal type:
Enhancing New Zealand's Clinical Trials Project
Lay summary
We have assembled a national team of experts, plus a broad stakeholder group and international advisory panel, to investigate the clinical trials landscape across Aotearoa New Zealand. We will utilise existing data sources plus direct retrieval from organisations undertaking clinical trials to identifiy clinical trial activity, capability in clinical trial design, execution, resourcing, translation and implementation, and how this activity and capability are positioned and accessed across geographical, social and ethnic domains in Aotearoa New Zealand. These findings will be synthesised with in-depth review of international evidence and best practice, leading to the development of evidence-informed recommendations on how Aotearoa New Zealand can develop a national, equitable, sustainable and embedded clinical trials enterprise. Such an enterprise will enhance the visibility of clinical trials within a learning healthcare system, increasing equity of access to clinical trials and contributing to improved and more equitable health outcomes for New Zealanders.